Lv51
1326 积分 2026-01-12 加入
Estimating Survival in Patients With Lung Cancer and Brain Metastases
48秒前
待确认
Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC
7分钟前
已完结
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
8分钟前
已完结
First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases
10分钟前
已完结
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
11分钟前
求助中
Immunotherapy in lung cancer brain metastases
18分钟前
已完结
Lung cancer: current therapies and new targeted treatments
25分钟前
已完结
A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
27分钟前
已完结
Brain Metastasis Treatment: The Place of Tyrosine Kinase Inhibitors and How to Facilitate Their Diffusion across the Blood–Brain Barrier
30分钟前
已完结
Brain metastasis screening in the molecular age
55分钟前
已关闭
皖公网安备34019202002308
